--- title: "PFE.US (PFE.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/PFE.US/news.md" symbol: "PFE.US" name: "PFE.US" parent: "https://longbridge.com/en/quote/PFE.US.md" datetime: "2026-05-20T09:15:12.521Z" locales: - [en](https://longbridge.com/en/quote/PFE.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/PFE.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/PFE.US/news.md) --- # PFE.US (PFE.US) — Related News ### [](https://longbridge.com/en/news/287036704.md) *2026-05-20T09:13:08.000Z* > Pfizer's official website shows that the Phase II clinical results are positive, accelerating the advancement of the key ### [Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | PFE Stock News](https://longbridge.com/en/news/287035698.md) *2026-05-20T01:05:28.000Z* > Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | PFE Stock New ### [Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/286964032.md) *2026-05-19T20:36:39.000Z* > Pfizer Inc. (PFE) shares rose 1.30% to $25.66 on a challenging trading day for the market, outperforming competitors lik ### [Target Upgraded, Pfizer Downgraded: Updated Rankings on Top Blue-Chip Stocks](https://longbridge.com/en/news/286812961.md) *2026-05-18T20:00:21.000Z* > Recent updates on blue-chip stocks show significant changes in ratings. Target Corporation has been upgraded from Neutra ### [](https://longbridge.com/en/news/286791210.md) *2026-05-18T15:05:43.000Z* > Trump will announce drug discount benefits today ### [Thrivent Financial for Lutherans Acquires 72,504 Shares of Pfizer Inc. $PFE](https://longbridge.com/en/news/286761926.md) *2026-05-18T11:21:30.000Z* > Thrivent Financial for Lutherans increased its holdings in Pfizer Inc. by 9.8% in Q4, acquiring 72,504 shares, bringing ### [Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 | PFE Stock News](https://longbridge.com/en/news/286767626.md) *2026-05-18T04:00:00.000Z* > Astellas Pharma Inc. will present new oncology data at the 2026 ASCO Annual Meeting, highlighting long-term outcomes and